Our Products

Enhancing pharmaceutical products so that patients can experience therapeutic efficacy with fewer side effects and more convenient dosing is Depomed’s primary goal. To date, the company has advanced two products to market, each formulated with the company’s proprietary AcuForm™ delivery technology.

Once-daily treatment for adults with type 2 diabetes

• Approved in the United States and Canada
• Available in 500 mg and 1,000 mg tablets
• Marketed by Santarus, Inc. (United States)
• Marketed by Biovail Corporation (Canada)

Once-daily treatment for uncomplicated urinary tract infections

• Approved in the United States and Sweden
• Available in 500 mg tablets
• Marketed by Watson Pharmaceuticals (United States) and licensed to Rottapharm/Madaus (Europe)

Full prescribing and safety information can be found at www.glumetzaxr.com and www.proquinxr.com.

If you have any questions regarding our marketing products, please call 1.866.458.6389.